nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—ALB—ulcerative colitis	0.144	0.512	CbGaD
Erlotinib—ABCB1—ulcerative colitis	0.137	0.488	CbGaD
Erlotinib—CYP1A1—Nicotine—ulcerative colitis	0.0321	0.0754	CbGbCtD
Erlotinib—CYP1A1—Cholecalciferol—ulcerative colitis	0.0288	0.0676	CbGbCtD
Erlotinib—CYP1B1—Dexamethasone—ulcerative colitis	0.0284	0.0667	CbGbCtD
Erlotinib—ABCG2—Sulfasalazine—ulcerative colitis	0.027	0.0635	CbGbCtD
Erlotinib—ABCG2—Hydrocortisone—ulcerative colitis	0.0217	0.051	CbGbCtD
Erlotinib—CYP2C8—Nicotine—ulcerative colitis	0.0185	0.0435	CbGbCtD
Erlotinib—CYP3A4—Budesonide—ulcerative colitis	0.0173	0.0405	CbGbCtD
Erlotinib—CYP2C8—Cholecalciferol—ulcerative colitis	0.0166	0.039	CbGbCtD
Erlotinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.015	0.0352	CbGbCtD
Erlotinib—ALB—Prednisone—ulcerative colitis	0.0149	0.035	CbGbCtD
Erlotinib—CYP1A2—Nicotine—ulcerative colitis	0.0143	0.0337	CbGbCtD
Erlotinib—ABCG2—Dexamethasone—ulcerative colitis	0.0135	0.0317	CbGbCtD
Erlotinib—ABCB1—Methylprednisolone—ulcerative colitis	0.0129	0.0302	CbGbCtD
Erlotinib—CYP1A1—Dexamethasone—ulcerative colitis	0.0125	0.0293	CbGbCtD
Erlotinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.012	0.0282	CbGbCtD
Erlotinib—CYP2D6—Nicotine—ulcerative colitis	0.0118	0.0277	CbGbCtD
Erlotinib—CYP2C8—Hydrocortisone—ulcerative colitis	0.0116	0.0271	CbGbCtD
Erlotinib—CYP2D6—Cholecalciferol—ulcerative colitis	0.0106	0.0249	CbGbCtD
Erlotinib—ABCB1—Betamethasone—ulcerative colitis	0.00836	0.0196	CbGbCtD
Erlotinib—ABCB1—Prednisolone—ulcerative colitis	0.00825	0.0194	CbGbCtD
Erlotinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00782	0.0184	CbGbCtD
Erlotinib—ABCB1—Prednisone—ulcerative colitis	0.00779	0.0183	CbGbCtD
Erlotinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00771	0.0181	CbGbCtD
Erlotinib—CYP3A4—Nicotine—ulcerative colitis	0.00751	0.0176	CbGbCtD
Erlotinib—CYP3A5—Dexamethasone—ulcerative colitis	0.00748	0.0176	CbGbCtD
Erlotinib—CYP2C8—Dexamethasone—ulcerative colitis	0.00719	0.0169	CbGbCtD
Erlotinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00674	0.0158	CbGbCtD
Erlotinib—CYP3A4—Triamcinolone—ulcerative colitis	0.00584	0.0137	CbGbCtD
Erlotinib—ORM1—bile—ulcerative colitis	0.00531	0.145	CbGeAlD
Erlotinib—CYP3A4—Betamethasone—ulcerative colitis	0.00501	0.0118	CbGbCtD
Erlotinib—CYP3A4—Prednisolone—ulcerative colitis	0.00494	0.0116	CbGbCtD
Erlotinib—ABCB1—Dexamethasone—ulcerative colitis	0.00487	0.0114	CbGbCtD
Erlotinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00469	0.011	CbGbCtD
Erlotinib—CYP3A4—Prednisone—ulcerative colitis	0.00467	0.011	CbGbCtD
Erlotinib—CYP2D6—Dexamethasone—ulcerative colitis	0.00458	0.0108	CbGbCtD
Erlotinib—Vandetanib—RIPK2—ulcerative colitis	0.00367	0.794	CrCbGaD
Erlotinib—CYP3A4—Dexamethasone—ulcerative colitis	0.00292	0.00685	CbGbCtD
Erlotinib—NR1I2—digestive system—ulcerative colitis	0.0019	0.0518	CbGeAlD
Erlotinib—JAK3—lymphoid tissue—ulcerative colitis	0.00154	0.0419	CbGeAlD
Erlotinib—JAK3—digestive system—ulcerative colitis	0.00152	0.0414	CbGeAlD
Erlotinib—NR1I2—liver—ulcerative colitis	0.00141	0.0386	CbGeAlD
Erlotinib—FLT3—lymphoid tissue—ulcerative colitis	0.00121	0.0331	CbGeAlD
Erlotinib—TNK1—liver—ulcerative colitis	0.00104	0.0283	CbGeAlD
Erlotinib—ULK3—digestive system—ulcerative colitis	0.00103	0.0282	CbGeAlD
Erlotinib—MKNK1—lymphoid tissue—ulcerative colitis	0.000983	0.0269	CbGeAlD
Erlotinib—MKNK1—digestive system—ulcerative colitis	0.000971	0.0265	CbGeAlD
Erlotinib—FLT3—liver—ulcerative colitis	0.000891	0.0243	CbGeAlD
Erlotinib—ABL2—liver—ulcerative colitis	0.000851	0.0232	CbGeAlD
Erlotinib—EGFR—liver—ulcerative colitis	0.00083	0.0227	CbGeAlD
Erlotinib—STK10—lymphoid tissue—ulcerative colitis	0.000809	0.0221	CbGeAlD
Erlotinib—PIP4K2C—liver—ulcerative colitis	0.000805	0.022	CbGeAlD
Erlotinib—STK10—digestive system—ulcerative colitis	0.0008	0.0218	CbGeAlD
Erlotinib—ULK3—liver—ulcerative colitis	0.000769	0.021	CbGeAlD
Erlotinib—UGT1A1—digestive system—ulcerative colitis	0.000755	0.0206	CbGeAlD
Erlotinib—MKNK1—liver—ulcerative colitis	0.000723	0.0198	CbGeAlD
Erlotinib—ABL1—smooth muscle tissue—ulcerative colitis	0.000698	0.0191	CbGeAlD
Erlotinib—SLK—liver—ulcerative colitis	0.000685	0.0187	CbGeAlD
Erlotinib—STK10—liver—ulcerative colitis	0.000596	0.0163	CbGeAlD
Erlotinib—CYP1B1—smooth muscle tissue—ulcerative colitis	0.000591	0.0161	CbGeAlD
Erlotinib—UGT1A1—liver—ulcerative colitis	0.000563	0.0154	CbGeAlD
Erlotinib—ABL1—lymphoid tissue—ulcerative colitis	0.000558	0.0152	CbGeAlD
Erlotinib—SLCO2B1—digestive system—ulcerative colitis	0.000556	0.0152	CbGeAlD
Erlotinib—ABL1—digestive system—ulcerative colitis	0.000551	0.0151	CbGeAlD
Erlotinib—MAP2K5—liver—ulcerative colitis	0.000532	0.0145	CbGeAlD
Erlotinib—CYP1B1—lymphoid tissue—ulcerative colitis	0.000472	0.0129	CbGeAlD
Erlotinib—CYP1B1—digestive system—ulcerative colitis	0.000466	0.0127	CbGeAlD
Erlotinib—CYP1A1—epithelium—ulcerative colitis	0.000433	0.0118	CbGeAlD
Erlotinib—ORM1—liver—ulcerative colitis	0.000432	0.0118	CbGeAlD
Erlotinib—SLCO2B1—liver—ulcerative colitis	0.000414	0.0113	CbGeAlD
Erlotinib—ABL1—liver—ulcerative colitis	0.00041	0.0112	CbGeAlD
Erlotinib—ALB—liver—ulcerative colitis	0.000379	0.0103	CbGeAlD
Erlotinib—CYP1B1—liver—ulcerative colitis	0.000348	0.0095	CbGeAlD
Erlotinib—CYP1A2—digestive system—ulcerative colitis	0.000334	0.00913	CbGeAlD
Erlotinib—Vandetanib—ALB—ulcerative colitis	0.000333	0.0721	CrCbGaD
Erlotinib—CYP1A1—digestive system—ulcerative colitis	0.00033	0.00901	CbGeAlD
Erlotinib—CYP3A5—digestive system—ulcerative colitis	0.000322	0.00881	CbGeAlD
Erlotinib—Gefitinib—ALB—ulcerative colitis	0.000316	0.0685	CrCbGaD
Erlotinib—Gefitinib—ABCB1—ulcerative colitis	0.000302	0.0653	CrCbGaD
Erlotinib—CYP2C8—liver—ulcerative colitis	0.000266	0.00727	CbGeAlD
Erlotinib—ABCG2—liver—ulcerative colitis	0.000259	0.00707	CbGeAlD
Erlotinib—CYP1A2—liver—ulcerative colitis	0.000249	0.00681	CbGeAlD
Erlotinib—CYP1A1—liver—ulcerative colitis	0.000246	0.00671	CbGeAlD
Erlotinib—CYP3A4—digestive system—ulcerative colitis	0.000242	0.00661	CbGeAlD
Erlotinib—CYP3A5—liver—ulcerative colitis	0.00024	0.00656	CbGeAlD
Erlotinib—CYP2D6—digestive system—ulcerative colitis	0.000238	0.00651	CbGeAlD
Erlotinib—ABCB1—epithelium—ulcerative colitis	0.000225	0.00615	CbGeAlD
Erlotinib—CYP3A4—liver—ulcerative colitis	0.00018	0.00493	CbGeAlD
Erlotinib—CYP2D6—liver—ulcerative colitis	0.000177	0.00485	CbGeAlD
Erlotinib—ABCB1—lymphoid tissue—ulcerative colitis	0.000173	0.00474	CbGeAlD
Erlotinib—ABCB1—digestive system—ulcerative colitis	0.000171	0.00468	CbGeAlD
Erlotinib—Dyspepsia—Mesalazine—ulcerative colitis	0.00014	0.000892	CcSEcCtD
Erlotinib—Eye disorder—Methylprednisolone—ulcerative colitis	0.00014	0.00089	CcSEcCtD
Erlotinib—Mental disorder—Hydrocortisone—ulcerative colitis	0.00014	0.000888	CcSEcCtD
Erlotinib—Erythema—Hydrocortisone—ulcerative colitis	0.000139	0.000883	CcSEcCtD
Erlotinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000139	0.000883	CcSEcCtD
Erlotinib—Neutropenia—Prednisone—ulcerative colitis	0.000138	0.000881	CcSEcCtD
Erlotinib—Pruritus—Budesonide—ulcerative colitis	0.000138	0.000881	CcSEcCtD
Erlotinib—Decreased appetite—Mesalazine—ulcerative colitis	0.000138	0.000881	CcSEcCtD
Erlotinib—Abdominal pain—Azathioprine—ulcerative colitis	0.000138	0.000879	CcSEcCtD
Erlotinib—Body temperature increased—Azathioprine—ulcerative colitis	0.000138	0.000879	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000137	0.000875	CcSEcCtD
Erlotinib—Fatigue—Mesalazine—ulcerative colitis	0.000137	0.000873	CcSEcCtD
Erlotinib—Haemoglobin—Betamethasone—ulcerative colitis	0.000137	0.000871	CcSEcCtD
Erlotinib—Haemoglobin—Dexamethasone—ulcerative colitis	0.000137	0.000871	CcSEcCtD
Erlotinib—Constipation—Mesalazine—ulcerative colitis	0.000136	0.000866	CcSEcCtD
Erlotinib—Pain—Mesalazine—ulcerative colitis	0.000136	0.000866	CcSEcCtD
Erlotinib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000136	0.000866	CcSEcCtD
Erlotinib—Haemorrhage—Betamethasone—ulcerative colitis	0.000136	0.000866	CcSEcCtD
Erlotinib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000135	0.000859	CcSEcCtD
Erlotinib—Arrhythmia—Triamcinolone—ulcerative colitis	0.000134	0.000853	CcSEcCtD
Erlotinib—Weight decreased—Prednisone—ulcerative colitis	0.000134	0.000853	CcSEcCtD
Erlotinib—Diarrhoea—Budesonide—ulcerative colitis	0.000134	0.000852	CcSEcCtD
Erlotinib—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000134	0.000851	CcSEcCtD
Erlotinib—Depression—Prednisone—ulcerative colitis	0.000132	0.000838	CcSEcCtD
Erlotinib—Mental disorder—Methylprednisolone—ulcerative colitis	0.000131	0.000835	CcSEcCtD
Erlotinib—Erythema—Triamcinolone—ulcerative colitis	0.000131	0.000831	CcSEcCtD
Erlotinib—Erythema—Methylprednisolone—ulcerative colitis	0.00013	0.000829	CcSEcCtD
Erlotinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.00013	0.000829	CcSEcCtD
Erlotinib—Acute coronary syndrome—Prednisone—ulcerative colitis	0.00013	0.000829	CcSEcCtD
Erlotinib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00013	0.000828	CcSEcCtD
Erlotinib—Myocardial infarction—Prednisone—ulcerative colitis	0.000129	0.000824	CcSEcCtD
Erlotinib—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000129	0.000824	CcSEcCtD
Erlotinib—Dizziness—Budesonide—ulcerative colitis	0.000129	0.000824	CcSEcCtD
Erlotinib—ABCB1—liver—ulcerative colitis	0.000128	0.00349	CbGeAlD
Erlotinib—Syncope—Prednisolone—ulcerative colitis	0.000127	0.000811	CcSEcCtD
Erlotinib—Eye disorder—Dexamethasone—ulcerative colitis	0.000127	0.00081	CcSEcCtD
Erlotinib—Eye disorder—Betamethasone—ulcerative colitis	0.000127	0.00081	CcSEcCtD
Erlotinib—Back pain—Triamcinolone—ulcerative colitis	0.000126	0.000804	CcSEcCtD
Erlotinib—Abdominal pain—Mesalazine—ulcerative colitis	0.000126	0.000801	CcSEcCtD
Erlotinib—Body temperature increased—Mesalazine—ulcerative colitis	0.000126	0.000801	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisolone—ulcerative colitis	0.000125	0.000794	CcSEcCtD
Erlotinib—Vomiting—Budesonide—ulcerative colitis	0.000124	0.000792	CcSEcCtD
Erlotinib—Syncope—Hydrocortisone—ulcerative colitis	0.000124	0.000792	CcSEcCtD
Erlotinib—Rash—Budesonide—ulcerative colitis	0.000123	0.000785	CcSEcCtD
Erlotinib—Dermatitis—Budesonide—ulcerative colitis	0.000123	0.000785	CcSEcCtD
Erlotinib—Headache—Budesonide—ulcerative colitis	0.000123	0.00078	CcSEcCtD
Erlotinib—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000122	0.000776	CcSEcCtD
Erlotinib—Arrhythmia—Dexamethasone—ulcerative colitis	0.000122	0.000774	CcSEcCtD
Erlotinib—Arrhythmia—Betamethasone—ulcerative colitis	0.000122	0.000774	CcSEcCtD
Erlotinib—Alopecia—Betamethasone—ulcerative colitis	0.00012	0.000766	CcSEcCtD
Erlotinib—Alopecia—Dexamethasone—ulcerative colitis	0.00012	0.000766	CcSEcCtD
Erlotinib—Diarrhoea—Azathioprine—ulcerative colitis	0.00012	0.000761	CcSEcCtD
Erlotinib—Haemoglobin—Prednisone—ulcerative colitis	0.000119	0.000758	CcSEcCtD
Erlotinib—Haemorrhage—Prednisone—ulcerative colitis	0.000119	0.000754	CcSEcCtD
Erlotinib—Erythema—Betamethasone—ulcerative colitis	0.000118	0.000754	CcSEcCtD
Erlotinib—Erythema—Dexamethasone—ulcerative colitis	0.000118	0.000754	CcSEcCtD
Erlotinib—Myalgia—Hydrocortisone—ulcerative colitis	0.000118	0.000752	CcSEcCtD
Erlotinib—Anxiety—Hydrocortisone—ulcerative colitis	0.000118	0.000749	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000117	0.000746	CcSEcCtD
Erlotinib—Syncope—Triamcinolone—ulcerative colitis	0.000117	0.000745	CcSEcCtD
Erlotinib—Syncope—Methylprednisolone—ulcerative colitis	0.000117	0.000744	CcSEcCtD
Erlotinib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000116	0.000741	CcSEcCtD
Erlotinib—Nausea—Budesonide—ulcerative colitis	0.000116	0.00074	CcSEcCtD
Erlotinib—Oedema—Prednisolone—ulcerative colitis	0.000116	0.000738	CcSEcCtD
Erlotinib—Dizziness—Azathioprine—ulcerative colitis	0.000116	0.000735	CcSEcCtD
Erlotinib—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000115	0.000731	CcSEcCtD
Erlotinib—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000114	0.000729	CcSEcCtD
Erlotinib—Asthenia—Mesalazine—ulcerative colitis	0.000114	0.000727	CcSEcCtD
Erlotinib—Shock—Prednisolone—ulcerative colitis	0.000114	0.000726	CcSEcCtD
Erlotinib—Cough—Triamcinolone—ulcerative colitis	0.000114	0.000725	CcSEcCtD
Erlotinib—Oedema—Hydrocortisone—ulcerative colitis	0.000113	0.00072	CcSEcCtD
Erlotinib—Pruritus—Mesalazine—ulcerative colitis	0.000113	0.000717	CcSEcCtD
Erlotinib—Infection—Hydrocortisone—ulcerative colitis	0.000112	0.000716	CcSEcCtD
Erlotinib—Shock—Hydrocortisone—ulcerative colitis	0.000111	0.000709	CcSEcCtD
Erlotinib—Myalgia—Triamcinolone—ulcerative colitis	0.000111	0.000708	CcSEcCtD
Erlotinib—Vomiting—Azathioprine—ulcerative colitis	0.000111	0.000707	CcSEcCtD
Erlotinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000111	0.000707	CcSEcCtD
Erlotinib—Myalgia—Methylprednisolone—ulcerative colitis	0.000111	0.000706	CcSEcCtD
Erlotinib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000111	0.000706	CcSEcCtD
Erlotinib—Eye disorder—Prednisone—ulcerative colitis	0.000111	0.000705	CcSEcCtD
Erlotinib—Anxiety—Methylprednisolone—ulcerative colitis	0.000111	0.000704	CcSEcCtD
Erlotinib—Rash—Azathioprine—ulcerative colitis	0.00011	0.000701	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00011	0.000701	CcSEcCtD
Erlotinib—Dermatitis—Azathioprine—ulcerative colitis	0.00011	0.000701	CcSEcCtD
Erlotinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.00011	0.0007	CcSEcCtD
Erlotinib—Headache—Azathioprine—ulcerative colitis	0.000109	0.000697	CcSEcCtD
Erlotinib—Diarrhoea—Mesalazine—ulcerative colitis	0.000109	0.000693	CcSEcCtD
Erlotinib—Anorexia—Hydrocortisone—ulcerative colitis	0.000108	0.000687	CcSEcCtD
Erlotinib—Oedema—Triamcinolone—ulcerative colitis	0.000107	0.000678	CcSEcCtD
Erlotinib—Syncope—Dexamethasone—ulcerative colitis	0.000106	0.000676	CcSEcCtD
Erlotinib—Syncope—Betamethasone—ulcerative colitis	0.000106	0.000676	CcSEcCtD
Erlotinib—Arrhythmia—Prednisone—ulcerative colitis	0.000106	0.000674	CcSEcCtD
Erlotinib—Infection—Triamcinolone—ulcerative colitis	0.000106	0.000674	CcSEcCtD
Erlotinib—Infection—Methylprednisolone—ulcerative colitis	0.000106	0.000672	CcSEcCtD
Erlotinib—Dizziness—Mesalazine—ulcerative colitis	0.000105	0.00067	CcSEcCtD
Erlotinib—Shock—Triamcinolone—ulcerative colitis	0.000105	0.000667	CcSEcCtD
Erlotinib—Insomnia—Prednisolone—ulcerative colitis	0.000105	0.000667	CcSEcCtD
Erlotinib—Alopecia—Prednisone—ulcerative colitis	0.000105	0.000667	CcSEcCtD
Erlotinib—Shock—Methylprednisolone—ulcerative colitis	0.000105	0.000666	CcSEcCtD
Erlotinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000104	0.000664	CcSEcCtD
Erlotinib—Loss of consciousness—Betamethasone—ulcerative colitis	0.000104	0.000663	CcSEcCtD
Erlotinib—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000104	0.000663	CcSEcCtD
Erlotinib—Mental disorder—Prednisone—ulcerative colitis	0.000104	0.000661	CcSEcCtD
Erlotinib—Nausea—Azathioprine—ulcerative colitis	0.000104	0.000661	CcSEcCtD
Erlotinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000103	0.000657	CcSEcCtD
Erlotinib—Erythema—Prednisone—ulcerative colitis	0.000103	0.000657	CcSEcCtD
Erlotinib—Malnutrition—Prednisone—ulcerative colitis	0.000103	0.000657	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000103	0.000656	CcSEcCtD
Erlotinib—Insomnia—Hydrocortisone—ulcerative colitis	0.000102	0.000652	CcSEcCtD
Erlotinib—Vomiting—Mesalazine—ulcerative colitis	0.000101	0.000644	CcSEcCtD
Erlotinib—Myalgia—Betamethasone—ulcerative colitis	0.000101	0.000642	CcSEcCtD
Erlotinib—Myalgia—Dexamethasone—ulcerative colitis	0.000101	0.000642	CcSEcCtD
Erlotinib—Anxiety—Dexamethasone—ulcerative colitis	0.0001	0.00064	CcSEcCtD
Erlotinib—Anxiety—Betamethasone—ulcerative colitis	0.0001	0.00064	CcSEcCtD
Erlotinib—Rash—Mesalazine—ulcerative colitis	0.0001	0.000639	CcSEcCtD
Erlotinib—Dermatitis—Mesalazine—ulcerative colitis	0.0001	0.000638	CcSEcCtD
Erlotinib—Headache—Mesalazine—ulcerative colitis	9.97e-05	0.000635	CcSEcCtD
Erlotinib—Dyspepsia—Hydrocortisone—ulcerative colitis	9.96e-05	0.000634	CcSEcCtD
Erlotinib—Pain—Prednisolone—ulcerative colitis	9.91e-05	0.000631	CcSEcCtD
Erlotinib—Decreased appetite—Hydrocortisone—ulcerative colitis	9.84e-05	0.000626	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	9.77e-05	0.000622	CcSEcCtD
Erlotinib—Fatigue—Hydrocortisone—ulcerative colitis	9.76e-05	0.000621	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	9.71e-05	0.000618	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	9.69e-05	0.000617	CcSEcCtD
Erlotinib—Pain—Hydrocortisone—ulcerative colitis	9.68e-05	0.000616	CcSEcCtD
Erlotinib—Oedema—Betamethasone—ulcerative colitis	9.67e-05	0.000616	CcSEcCtD
Erlotinib—Oedema—Dexamethasone—ulcerative colitis	9.67e-05	0.000616	CcSEcCtD
Erlotinib—Insomnia—Triamcinolone—ulcerative colitis	9.64e-05	0.000614	CcSEcCtD
Erlotinib—Insomnia—Methylprednisolone—ulcerative colitis	9.62e-05	0.000612	CcSEcCtD
Erlotinib—Infection—Dexamethasone—ulcerative colitis	9.6e-05	0.000611	CcSEcCtD
Erlotinib—Infection—Betamethasone—ulcerative colitis	9.6e-05	0.000611	CcSEcCtD
Erlotinib—Shock—Betamethasone—ulcerative colitis	9.51e-05	0.000606	CcSEcCtD
Erlotinib—Shock—Dexamethasone—ulcerative colitis	9.51e-05	0.000606	CcSEcCtD
Erlotinib—Dyspnoea—Triamcinolone—ulcerative colitis	9.5e-05	0.000605	CcSEcCtD
Erlotinib—Nervous system disorder—Betamethasone—ulcerative colitis	9.48e-05	0.000604	CcSEcCtD
Erlotinib—Nervous system disorder—Dexamethasone—ulcerative colitis	9.48e-05	0.000604	CcSEcCtD
Erlotinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	9.47e-05	0.000603	CcSEcCtD
Erlotinib—Thrombocytopenia—Betamethasone—ulcerative colitis	9.47e-05	0.000603	CcSEcCtD
Erlotinib—Nausea—Mesalazine—ulcerative colitis	9.45e-05	0.000602	CcSEcCtD
Erlotinib—Dyspepsia—Triamcinolone—ulcerative colitis	9.38e-05	0.000597	CcSEcCtD
Erlotinib—Dyspepsia—Methylprednisolone—ulcerative colitis	9.36e-05	0.000596	CcSEcCtD
Erlotinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	9.25e-05	0.000589	CcSEcCtD
Erlotinib—Syncope—Prednisone—ulcerative colitis	9.25e-05	0.000589	CcSEcCtD
Erlotinib—Anorexia—Dexamethasone—ulcerative colitis	9.22e-05	0.000587	CcSEcCtD
Erlotinib—Anorexia—Betamethasone—ulcerative colitis	9.22e-05	0.000587	CcSEcCtD
Erlotinib—Fatigue—Triamcinolone—ulcerative colitis	9.19e-05	0.000585	CcSEcCtD
Erlotinib—Fatigue—Methylprednisolone—ulcerative colitis	9.17e-05	0.000584	CcSEcCtD
Erlotinib—Pain—Triamcinolone—ulcerative colitis	9.11e-05	0.00058	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisone—ulcerative colitis	9.07e-05	0.000577	CcSEcCtD
Erlotinib—Abdominal pain—Hydrocortisone—ulcerative colitis	8.94e-05	0.00057	CcSEcCtD
Erlotinib—Body temperature increased—Hydrocortisone—ulcerative colitis	8.94e-05	0.00057	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	8.81e-05	0.000561	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	8.81e-05	0.000561	CcSEcCtD
Erlotinib—Myalgia—Prednisone—ulcerative colitis	8.78e-05	0.000559	CcSEcCtD
Erlotinib—Arthralgia—Prednisone—ulcerative colitis	8.78e-05	0.000559	CcSEcCtD
Erlotinib—Anxiety—Prednisone—ulcerative colitis	8.75e-05	0.000557	CcSEcCtD
Erlotinib—Insomnia—Betamethasone—ulcerative colitis	8.74e-05	0.000557	CcSEcCtD
Erlotinib—Insomnia—Dexamethasone—ulcerative colitis	8.74e-05	0.000557	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	8.72e-05	0.000555	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	8.69e-05	0.000553	CcSEcCtD
Erlotinib—Dyspepsia—Dexamethasone—ulcerative colitis	8.51e-05	0.000542	CcSEcCtD
Erlotinib—Dyspepsia—Betamethasone—ulcerative colitis	8.51e-05	0.000542	CcSEcCtD
Erlotinib—Body temperature increased—Triamcinolone—ulcerative colitis	8.42e-05	0.000536	CcSEcCtD
Erlotinib—Oedema—Prednisone—ulcerative colitis	8.42e-05	0.000536	CcSEcCtD
Erlotinib—Abdominal pain—Methylprednisolone—ulcerative colitis	8.4e-05	0.000535	CcSEcCtD
Erlotinib—Decreased appetite—Betamethasone—ulcerative colitis	8.4e-05	0.000535	CcSEcCtD
Erlotinib—Decreased appetite—Dexamethasone—ulcerative colitis	8.4e-05	0.000535	CcSEcCtD
Erlotinib—Infection—Prednisone—ulcerative colitis	8.36e-05	0.000533	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	8.35e-05	0.000531	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	8.35e-05	0.000531	CcSEcCtD
Erlotinib—Fatigue—Dexamethasone—ulcerative colitis	8.33e-05	0.000531	CcSEcCtD
Erlotinib—Fatigue—Betamethasone—ulcerative colitis	8.33e-05	0.000531	CcSEcCtD
Erlotinib—Shock—Prednisone—ulcerative colitis	8.28e-05	0.000527	CcSEcCtD
Erlotinib—Pain—Betamethasone—ulcerative colitis	8.27e-05	0.000526	CcSEcCtD
Erlotinib—Pain—Dexamethasone—ulcerative colitis	8.27e-05	0.000526	CcSEcCtD
Erlotinib—Nervous system disorder—Prednisone—ulcerative colitis	8.26e-05	0.000526	CcSEcCtD
Erlotinib—Skin disorder—Prednisone—ulcerative colitis	8.18e-05	0.000521	CcSEcCtD
Erlotinib—Asthenia—Hydrocortisone—ulcerative colitis	8.12e-05	0.000517	CcSEcCtD
Erlotinib—Anorexia—Prednisone—ulcerative colitis	8.03e-05	0.000511	CcSEcCtD
Erlotinib—Pruritus—Hydrocortisone—ulcerative colitis	8.01e-05	0.00051	CcSEcCtD
Erlotinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	7.91e-05	0.000503	CcSEcCtD
Erlotinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	7.91e-05	0.000503	CcSEcCtD
Erlotinib—Diarrhoea—Hydrocortisone—ulcerative colitis	7.74e-05	0.000493	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	7.67e-05	0.000488	CcSEcCtD
Erlotinib—Dizziness—Prednisolone—ulcerative colitis	7.66e-05	0.000488	CcSEcCtD
Erlotinib—Asthenia—Triamcinolone—ulcerative colitis	7.64e-05	0.000487	CcSEcCtD
Erlotinib—Body temperature increased—Dexamethasone—ulcerative colitis	7.64e-05	0.000487	CcSEcCtD
Erlotinib—Abdominal pain—Betamethasone—ulcerative colitis	7.64e-05	0.000487	CcSEcCtD
Erlotinib—Abdominal pain—Dexamethasone—ulcerative colitis	7.64e-05	0.000487	CcSEcCtD
Erlotinib—Body temperature increased—Betamethasone—ulcerative colitis	7.64e-05	0.000487	CcSEcCtD
Erlotinib—Asthenia—Methylprednisolone—ulcerative colitis	7.63e-05	0.000486	CcSEcCtD
Erlotinib—Insomnia—Prednisone—ulcerative colitis	7.61e-05	0.000485	CcSEcCtD
Erlotinib—Pruritus—Triamcinolone—ulcerative colitis	7.54e-05	0.00048	CcSEcCtD
Erlotinib—Pruritus—Methylprednisolone—ulcerative colitis	7.52e-05	0.000479	CcSEcCtD
Erlotinib—Dizziness—Hydrocortisone—ulcerative colitis	7.48e-05	0.000476	CcSEcCtD
Erlotinib—Dyspepsia—Prednisone—ulcerative colitis	7.41e-05	0.000472	CcSEcCtD
Erlotinib—Decreased appetite—Prednisone—ulcerative colitis	7.32e-05	0.000466	CcSEcCtD
Erlotinib—Rash—Prednisolone—ulcerative colitis	7.31e-05	0.000465	CcSEcCtD
Erlotinib—Dermatitis—Prednisolone—ulcerative colitis	7.3e-05	0.000465	CcSEcCtD
Erlotinib—Diarrhoea—Methylprednisolone—ulcerative colitis	7.27e-05	0.000463	CcSEcCtD
Erlotinib—Fatigue—Prednisone—ulcerative colitis	7.26e-05	0.000462	CcSEcCtD
Erlotinib—Headache—Prednisolone—ulcerative colitis	7.26e-05	0.000462	CcSEcCtD
Erlotinib—Constipation—Prednisone—ulcerative colitis	7.2e-05	0.000458	CcSEcCtD
Erlotinib—Vomiting—Hydrocortisone—ulcerative colitis	7.19e-05	0.000458	CcSEcCtD
Erlotinib—Rash—Hydrocortisone—ulcerative colitis	7.13e-05	0.000454	CcSEcCtD
Erlotinib—Dermatitis—Hydrocortisone—ulcerative colitis	7.13e-05	0.000454	CcSEcCtD
Erlotinib—Headache—Hydrocortisone—ulcerative colitis	7.09e-05	0.000451	CcSEcCtD
Erlotinib—Dizziness—Triamcinolone—ulcerative colitis	7.05e-05	0.000449	CcSEcCtD
Erlotinib—Dizziness—Methylprednisolone—ulcerative colitis	7.03e-05	0.000448	CcSEcCtD
Erlotinib—Asthenia—Betamethasone—ulcerative colitis	6.94e-05	0.000442	CcSEcCtD
Erlotinib—Asthenia—Dexamethasone—ulcerative colitis	6.94e-05	0.000442	CcSEcCtD
Erlotinib—Gastrointestinal pain—Prednisone—ulcerative colitis	6.88e-05	0.000438	CcSEcCtD
Erlotinib—Nausea—Prednisolone—ulcerative colitis	6.88e-05	0.000438	CcSEcCtD
Erlotinib—Pruritus—Betamethasone—ulcerative colitis	6.84e-05	0.000435	CcSEcCtD
Erlotinib—Pruritus—Dexamethasone—ulcerative colitis	6.84e-05	0.000435	CcSEcCtD
Erlotinib—Vomiting—Triamcinolone—ulcerative colitis	6.77e-05	0.000431	CcSEcCtD
Erlotinib—Vomiting—Methylprednisolone—ulcerative colitis	6.76e-05	0.00043	CcSEcCtD
Erlotinib—Nausea—Hydrocortisone—ulcerative colitis	6.72e-05	0.000428	CcSEcCtD
Erlotinib—Rash—Triamcinolone—ulcerative colitis	6.72e-05	0.000428	CcSEcCtD
Erlotinib—Dermatitis—Triamcinolone—ulcerative colitis	6.71e-05	0.000427	CcSEcCtD
Erlotinib—Rash—Methylprednisolone—ulcerative colitis	6.7e-05	0.000427	CcSEcCtD
Erlotinib—Dermatitis—Methylprednisolone—ulcerative colitis	6.7e-05	0.000426	CcSEcCtD
Erlotinib—Headache—Triamcinolone—ulcerative colitis	6.67e-05	0.000425	CcSEcCtD
Erlotinib—Headache—Methylprednisolone—ulcerative colitis	6.66e-05	0.000424	CcSEcCtD
Erlotinib—Body temperature increased—Prednisone—ulcerative colitis	6.66e-05	0.000424	CcSEcCtD
Erlotinib—Abdominal pain—Prednisone—ulcerative colitis	6.66e-05	0.000424	CcSEcCtD
Erlotinib—Diarrhoea—Dexamethasone—ulcerative colitis	6.61e-05	0.000421	CcSEcCtD
Erlotinib—Diarrhoea—Betamethasone—ulcerative colitis	6.61e-05	0.000421	CcSEcCtD
Erlotinib—Dizziness—Dexamethasone—ulcerative colitis	6.39e-05	0.000407	CcSEcCtD
Erlotinib—Dizziness—Betamethasone—ulcerative colitis	6.39e-05	0.000407	CcSEcCtD
Erlotinib—Nausea—Triamcinolone—ulcerative colitis	6.33e-05	0.000403	CcSEcCtD
Erlotinib—Nausea—Methylprednisolone—ulcerative colitis	6.31e-05	0.000402	CcSEcCtD
Erlotinib—Vomiting—Dexamethasone—ulcerative colitis	6.15e-05	0.000391	CcSEcCtD
Erlotinib—Vomiting—Betamethasone—ulcerative colitis	6.15e-05	0.000391	CcSEcCtD
Erlotinib—Rash—Betamethasone—ulcerative colitis	6.1e-05	0.000388	CcSEcCtD
Erlotinib—Rash—Dexamethasone—ulcerative colitis	6.1e-05	0.000388	CcSEcCtD
Erlotinib—Dermatitis—Dexamethasone—ulcerative colitis	6.09e-05	0.000388	CcSEcCtD
Erlotinib—Dermatitis—Betamethasone—ulcerative colitis	6.09e-05	0.000388	CcSEcCtD
Erlotinib—Headache—Betamethasone—ulcerative colitis	6.06e-05	0.000386	CcSEcCtD
Erlotinib—Headache—Dexamethasone—ulcerative colitis	6.06e-05	0.000386	CcSEcCtD
Erlotinib—Asthenia—Prednisone—ulcerative colitis	6.04e-05	0.000385	CcSEcCtD
Erlotinib—Pruritus—Prednisone—ulcerative colitis	5.96e-05	0.000379	CcSEcCtD
Erlotinib—Diarrhoea—Prednisone—ulcerative colitis	5.76e-05	0.000367	CcSEcCtD
Erlotinib—Nausea—Dexamethasone—ulcerative colitis	5.74e-05	0.000366	CcSEcCtD
Erlotinib—Nausea—Betamethasone—ulcerative colitis	5.74e-05	0.000366	CcSEcCtD
Erlotinib—Dizziness—Prednisone—ulcerative colitis	5.57e-05	0.000354	CcSEcCtD
Erlotinib—Vomiting—Prednisone—ulcerative colitis	5.35e-05	0.000341	CcSEcCtD
Erlotinib—Rash—Prednisone—ulcerative colitis	5.31e-05	0.000338	CcSEcCtD
Erlotinib—Dermatitis—Prednisone—ulcerative colitis	5.3e-05	0.000338	CcSEcCtD
Erlotinib—Headache—Prednisone—ulcerative colitis	5.27e-05	0.000336	CcSEcCtD
Erlotinib—Nausea—Prednisone—ulcerative colitis	5e-05	0.000318	CcSEcCtD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	1.42e-05	0.000149	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL1B—ulcerative colitis	1.41e-05	0.000149	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL2—ulcerative colitis	1.41e-05	0.000148	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DLD—ulcerative colitis	1.4e-05	0.000148	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.39e-05	0.000147	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NOD2—ulcerative colitis	1.39e-05	0.000147	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD14—ulcerative colitis	1.39e-05	0.000146	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—JAK2—ulcerative colitis	1.38e-05	0.000146	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS1—ulcerative colitis	1.38e-05	0.000145	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCR2—ulcerative colitis	1.37e-05	0.000145	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—IL2—ulcerative colitis	1.37e-05	0.000145	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—RELA—ulcerative colitis	1.37e-05	0.000145	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—JAK2—ulcerative colitis	1.37e-05	0.000145	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.37e-05	0.000144	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ADCY5—ulcerative colitis	1.36e-05	0.000144	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.35e-05	0.000143	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD4—ulcerative colitis	1.34e-05	0.000142	CbGpPWpGaD
Erlotinib—MKNK1—Disease—TGFB1—ulcerative colitis	1.34e-05	0.000142	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—RELA—ulcerative colitis	1.34e-05	0.000141	CbGpPWpGaD
Erlotinib—EGFR—Immune System—VCAM1—ulcerative colitis	1.34e-05	0.000141	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DQA1—ulcerative colitis	1.33e-05	0.000141	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—RELA—ulcerative colitis	1.33e-05	0.00014	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CALM3—ulcerative colitis	1.33e-05	0.00014	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CDH1—ulcerative colitis	1.33e-05	0.00014	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP9—ulcerative colitis	1.33e-05	0.00014	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ADCY5—ulcerative colitis	1.33e-05	0.00014	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DLD—ulcerative colitis	1.32e-05	0.000139	CbGpPWpGaD
Erlotinib—JAK3—Immune System—NFKB1—ulcerative colitis	1.32e-05	0.000139	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.31e-05	0.000138	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—NFKB1—ulcerative colitis	1.31e-05	0.000138	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.29e-05	0.000136	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR6—ulcerative colitis	1.29e-05	0.000136	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CXCL8—ulcerative colitis	1.26e-05	0.000133	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.25e-05	0.000132	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—ADCY5—ulcerative colitis	1.24e-05	0.000131	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CALM3—ulcerative colitis	1.24e-05	0.000131	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MAML2—ulcerative colitis	1.23e-05	0.000129	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.21e-05	0.000128	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—JAK2—ulcerative colitis	1.21e-05	0.000128	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.21e-05	0.000128	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL2—ulcerative colitis	1.21e-05	0.000127	CbGpPWpGaD
Erlotinib—JAK3—Immune System—STAT3—ulcerative colitis	1.18e-05	0.000125	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.18e-05	0.000125	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—STAT3—ulcerative colitis	1.18e-05	0.000124	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—RELA—ulcerative colitis	1.17e-05	0.000124	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.17e-05	0.000123	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CRP—ulcerative colitis	1.16e-05	0.000122	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—NFKB1—ulcerative colitis	1.16e-05	0.000122	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.15e-05	0.000122	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—IL6—ulcerative colitis	1.15e-05	0.000122	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD4—ulcerative colitis	1.15e-05	0.000121	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP9—ulcerative colitis	1.14e-05	0.00012	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PTGER4—ulcerative colitis	1.14e-05	0.00012	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP9—ulcerative colitis	1.13e-05	0.000119	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ADCY5—ulcerative colitis	1.13e-05	0.000119	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NFKB1—ulcerative colitis	1.13e-05	0.000119	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—RELA—ulcerative colitis	1.13e-05	0.000119	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CALM3—ulcerative colitis	1.13e-05	0.000119	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—NFKB1—ulcerative colitis	1.12e-05	0.000118	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DLD—ulcerative colitis	1.12e-05	0.000118	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TLR4—ulcerative colitis	1.11e-05	0.000117	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-DRB1—ulcerative colitis	1.11e-05	0.000117	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD4—ulcerative colitis	1.1e-05	0.000116	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—MMP1—ulcerative colitis	1.1e-05	0.000116	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TGFB1—ulcerative colitis	1.09e-05	0.000115	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—IL6—ulcerative colitis	1.09e-05	0.000115	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.08e-05	0.000114	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TGFB1—ulcerative colitis	1.07e-05	0.000113	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ICAM1—ulcerative colitis	1.07e-05	0.000112	CbGpPWpGaD
Erlotinib—EGFR—Disease—ADCY5—ulcerative colitis	1.05e-05	0.00011	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—JAK2—ulcerative colitis	1.04e-05	0.00011	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—GHRL—ulcerative colitis	1.04e-05	0.00011	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ABCB1—ulcerative colitis	1.03e-05	0.000109	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.02e-05	0.000108	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—ulcerative colitis	1.02e-05	0.000108	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—STAT3—ulcerative colitis	1.02e-05	0.000107	CbGpPWpGaD
Erlotinib—MKNK1—Disease—IL6—ulcerative colitis	1.01e-05	0.000107	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—RELA—ulcerative colitis	1.01e-05	0.000107	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CALM3—ulcerative colitis	1.01e-05	0.000106	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.01e-05	0.000106	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—STAT3—ulcerative colitis	1.01e-05	0.000106	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.99e-06	0.000105	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RIPK2—ulcerative colitis	9.94e-06	0.000105	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CRP—ulcerative colitis	9.91e-06	0.000104	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—NFKB1—ulcerative colitis	9.9e-06	0.000104	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—IL6—ulcerative colitis	9.86e-06	0.000104	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ADCY5—ulcerative colitis	9.63e-06	0.000102	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ABCB1—ulcerative colitis	9.63e-06	0.000102	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CXCL8—ulcerative colitis	9.52e-06	0.0001	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—NFKB1—ulcerative colitis	9.51e-06	0.0001	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR4—ulcerative colitis	9.5e-06	0.0001	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DRB1—ulcerative colitis	9.49e-06	0.0001	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.43e-06	9.95e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CDH1—ulcerative colitis	9.42e-06	9.94e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFB1—ulcerative colitis	9.41e-06	9.92e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.41e-06	9.92e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TGFB1—ulcerative colitis	9.34e-06	9.84e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.26e-06	9.77e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ICAM1—ulcerative colitis	9.11e-06	9.6e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL2—ulcerative colitis	9.1e-06	9.59e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL6—ulcerative colitis	9.05e-06	9.55e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ADCY5—ulcerative colitis	8.98e-06	9.47e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS1—ulcerative colitis	8.97e-06	9.45e-05	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TP53—ulcerative colitis	8.82e-06	9.3e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ABCB1—ulcerative colitis	8.76e-06	9.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—ulcerative colitis	8.72e-06	9.19e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ADRB2—ulcerative colitis	8.62e-06	9.09e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DLD—ulcerative colitis	8.62e-06	9.09e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP9—ulcerative colitis	8.61e-06	9.08e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NFKB1—ulcerative colitis	8.52e-06	8.98e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—JAK2—ulcerative colitis	8.5e-06	8.97e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.49e-06	8.96e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS1—ulcerative colitis	8.47e-06	8.93e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.45e-06	8.9e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.33e-06	8.78e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.3e-06	8.75e-05	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—ulcerative colitis	8.27e-06	8.72e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—JAK2—ulcerative colitis	8.26e-06	8.71e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RELA—ulcerative colitis	8.24e-06	8.68e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—ulcerative colitis	8.23e-06	8.68e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ADCY5—ulcerative colitis	8.17e-06	8.62e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFNG—ulcerative colitis	8.11e-06	8.55e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CALM3—ulcerative colitis	8.07e-06	8.51e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CDH1—ulcerative colitis	8.05e-06	8.49e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—RELA—ulcerative colitis	8e-06	8.44e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD4—ulcerative colitis	7.83e-06	8.26e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	7.77e-06	8.19e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL8—ulcerative colitis	7.76e-06	8.18e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—JAK2—ulcerative colitis	7.75e-06	8.18e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TP53—ulcerative colitis	7.75e-06	8.17e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—JAK2—ulcerative colitis	7.73e-06	8.15e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS1—ulcerative colitis	7.72e-06	8.14e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—STAT3—ulcerative colitis	7.66e-06	8.07e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.64e-06	8.05e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CALM3—ulcerative colitis	7.63e-06	8.04e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL2—ulcerative colitis	7.42e-06	7.82e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ADCY5—ulcerative colitis	7.32e-06	7.72e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.29e-06	7.68e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—ulcerative colitis	7.27e-06	7.67e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—ulcerative colitis	7.23e-06	7.63e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2—ulcerative colitis	7.21e-06	7.6e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PPARG—ulcerative colitis	7.18e-06	7.57e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—ulcerative colitis	7.1e-06	7.48e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—ulcerative colitis	7.09e-06	7.48e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—JAK2—ulcerative colitis	7.06e-06	7.44e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL8—ulcerative colitis	7.05e-06	7.43e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—ulcerative colitis	7.04e-06	7.42e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—ulcerative colitis	7.02e-06	7.4e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.99e-06	7.37e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CALM3—ulcerative colitis	6.95e-06	7.33e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NFKB1—ulcerative colitis	6.95e-06	7.32e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFNG—ulcerative colitis	6.93e-06	7.31e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—RELA—ulcerative colitis	6.84e-06	7.21e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	6.77e-06	7.13e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2—ulcerative colitis	6.76e-06	7.13e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NFKB1—ulcerative colitis	6.75e-06	7.11e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2—ulcerative colitis	6.74e-06	7.1e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARG—ulcerative colitis	6.7e-06	7.06e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD4—ulcerative colitis	6.69e-06	7.06e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.68e-06	7.05e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.64e-06	7.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—JAK2—ulcerative colitis	6.52e-06	6.87e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALB—ulcerative colitis	6.46e-06	6.81e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	6.38e-06	6.72e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.33e-06	6.67e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	6.28e-06	6.62e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—STAT3—ulcerative colitis	6.24e-06	6.58e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—ulcerative colitis	6.21e-06	6.55e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—ulcerative colitis	6.18e-06	6.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD4—ulcerative colitis	6.18e-06	6.51e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2—ulcerative colitis	6.16e-06	6.49e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—ulcerative colitis	6.13e-06	6.47e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARG—ulcerative colitis	6.1e-06	6.43e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CALM3—ulcerative colitis	6.09e-06	6.42e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—STAT3—ulcerative colitis	6.06e-06	6.39e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALB—ulcerative colitis	6.02e-06	6.35e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCB1—ulcerative colitis	5.93e-06	6.25e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.91e-06	6.23e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	5.86e-06	6.17e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TP53—ulcerative colitis	5.84e-06	6.16e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—ulcerative colitis	5.79e-06	6.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NFKB1—ulcerative colitis	5.77e-06	6.08e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CALM3—ulcerative colitis	5.74e-06	6.05e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—ulcerative colitis	5.65e-06	5.96e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ADCY5—ulcerative colitis	5.53e-06	5.83e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALB—ulcerative colitis	5.48e-06	5.78e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	5.44e-06	5.73e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCB1—ulcerative colitis	5.41e-06	5.7e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	5.4e-06	5.69e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—ulcerative colitis	5.35e-06	5.64e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.31e-06	5.6e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—ulcerative colitis	5.28e-06	5.56e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—ulcerative colitis	5.27e-06	5.56e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—STAT3—ulcerative colitis	5.18e-06	5.46e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	5.07e-06	5.35e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ADCY5—ulcerative colitis	5.04e-06	5.32e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.86e-06	5.13e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—ulcerative colitis	4.8e-06	5.06e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—STAT3—ulcerative colitis	4.78e-06	5.04e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TP53—ulcerative colitis	4.76e-06	5.02e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.65e-06	4.9e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—JAK2—ulcerative colitis	4.56e-06	4.81e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.46e-06	4.71e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—ulcerative colitis	4.43e-06	4.68e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RELA—ulcerative colitis	4.42e-06	4.66e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.42e-06	4.66e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	4.37e-06	4.6e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—ulcerative colitis	4.36e-06	4.6e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TP53—ulcerative colitis	4.34e-06	4.58e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—ulcerative colitis	4.24e-06	4.47e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.17e-06	4.39e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—ulcerative colitis	4.17e-06	4.39e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	4.16e-06	4.39e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARG—ulcerative colitis	4.13e-06	4.35e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2—ulcerative colitis	3.98e-06	4.2e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—ulcerative colitis	3.96e-06	4.18e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—ulcerative colitis	3.93e-06	4.14e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.78e-06	3.99e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.78e-06	3.99e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—ulcerative colitis	3.77e-06	3.97e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARG—ulcerative colitis	3.76e-06	3.97e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.75e-06	3.96e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NFKB1—ulcerative colitis	3.73e-06	3.93e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—ulcerative colitis	3.71e-06	3.91e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—ulcerative colitis	3.62e-06	3.82e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.53e-06	3.72e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	3.44e-06	3.62e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—ulcerative colitis	3.4e-06	3.59e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—STAT3—ulcerative colitis	3.35e-06	3.53e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—ulcerative colitis	3.34e-06	3.52e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARG—ulcerative colitis	3.3e-06	3.47e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—ulcerative colitis	3.25e-06	3.42e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARG—ulcerative colitis	3.11e-06	3.27e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—ulcerative colitis	3.11e-06	3.27e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.98e-06	3.14e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—ulcerative colitis	2.96e-06	3.12e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—ulcerative colitis	2.96e-06	3.12e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.92e-06	3.08e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—ulcerative colitis	2.79e-06	2.94e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.72e-06	2.87e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.63e-06	2.77e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.59e-06	2.73e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TP53—ulcerative colitis	2.56e-06	2.7e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.44e-06	2.58e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—ulcerative colitis	2.37e-06	2.49e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—ulcerative colitis	2.34e-06	2.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.07e-06	2.18e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.03e-06	2.14e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.83e-06	1.92e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.6e-06	1.68e-05	CbGpPWpGaD
